A new method for measurement of total plasma PCSK9: clinical applications
Open Access
- 1 January 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 51 (1), 140-149
- https://doi.org/10.1194/jlr.m900273-jlr200
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Plasma PCSK9 levels correlate with cholesterol in men but not in womenBiochemical and Biophysical Research Communications, 2007
- The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African populationAtherosclerosis, 2007
- Après le récepteur des LDL et l'apolipoprotéine B, l'hypercholestérolémie familiale révèle son troisième protagoniste: PCSK9Annales d'Endocrinologie, 2007
- Unravelling the functional significance of PCSK9Current Opinion in Lipidology, 2007
- Effect of mutations in the PCSK9 gene on the cell surface LDL receptorsHuman Molecular Genetics, 2006
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseThe New England Journal of Medicine, 2006
- A Spectrum of PCSK9 Alleles Contributes to Plasma Levels of Low-Density Lipoprotein CholesterolAmerican Journal of Human Genetics, 2006
- Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 GeneArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Novel mutations of thePCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemiaHuman Mutation, 2005
- Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartmentProceedings of the National Academy of Sciences of the United States of America, 2005